Annual Cash & Cash Equivalents
$18.26 M
+$13.99 M+327.97%
December 31, 2023
Summary
- As of February 12, 2025, GRTX annual cash & cash equivalents is $18.26 million, with the most recent change of +$13.99 million (+327.97%) on December 31, 2023.
- During the last 3 years, GRTX annual cash & cash equivalents has risen by +$2.38 million (+15.03%).
- GRTX annual cash & cash equivalents is now -8.07% below its all-time high of $19.86 million, reached on December 31, 2021.
Performance
GRTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.46 M
-$2.29 M-21.34%
September 1, 2024
Summary
- As of February 12, 2025, GRTX quarterly cash and cash equivalents is $8.46 million, with the most recent change of -$2.29 million (-21.34%) on September 1, 2024.
- Over the past year, GRTX quarterly cash and cash equivalents has dropped by -$9.80 million (-53.69%).
- GRTX quarterly cash and cash equivalents is now -78.02% below its all-time high of $38.47 million, reached on June 30, 2021.
Performance
GRTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GRTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +328.0% | -53.7% |
| 3 y3 years | +15.0% | -53.7% |
| 5 y5 years | +23.3% | -53.7% |
GRTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.1% | +328.0% | -67.1% | +98.2% |
| 5 y | 5-year | -8.1% | +328.0% | -78.0% | +98.2% |
| alltime | all time | -8.1% | +328.0% | -78.0% | +98.2% |
Galera Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.46 M(-21.3%) |
| Jun 2024 | - | $10.75 M(-20.2%) |
| Mar 2024 | - | $13.47 M(-26.2%) |
| Dec 2023 | $18.26 M(+328.0%) | $18.26 M(-25.1%) |
| Sep 2023 | - | $24.38 M(+0.3%) |
| Jun 2023 | - | $24.30 M(-5.4%) |
| Mar 2023 | - | $25.69 M(+502.1%) |
| Dec 2022 | $4.27 M(-78.5%) | $4.27 M(-66.5%) |
| Sep 2022 | - | $12.73 M(-26.7%) |
| Jun 2022 | - | $17.38 M(-11.6%) |
| Mar 2022 | - | $19.64 M(-1.1%) |
| Dec 2021 | $19.86 M | $19.86 M(+12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $17.63 M(-54.2%) |
| Jun 2021 | - | $38.47 M(+181.0%) |
| Mar 2021 | - | $13.69 M(-13.8%) |
| Dec 2020 | $15.87 M(-13.5%) | $15.87 M(+4.2%) |
| Sep 2020 | - | $15.23 M(-4.1%) |
| Jun 2020 | - | $15.88 M(-26.4%) |
| Mar 2020 | - | $21.58 M(+17.6%) |
| Dec 2019 | $18.36 M(+23.9%) | $18.36 M(+16.8%) |
| Sep 2019 | - | $15.72 M(-2.9%) |
| Jun 2019 | - | $16.20 M(+9.3%) |
| Dec 2018 | $14.81 M(+140.1%) | $14.81 M |
| Dec 2017 | $6.17 M | - |
FAQ
- What is Galera Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Galera Therapeutics?
- What is Galera Therapeutics annual cash & cash equivalents year-on-year change?
- What is Galera Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Galera Therapeutics?
- What is Galera Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Galera Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of GRTX is $18.26 M
What is the all time high annual cash & cash equivalents for Galera Therapeutics?
Galera Therapeutics all-time high annual cash & cash equivalents is $19.86 M
What is Galera Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, GRTX annual cash & cash equivalents has changed by +$13.99 M (+327.97%)
What is Galera Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GRTX is $8.46 M
What is the all time high quarterly cash and cash equivalents for Galera Therapeutics?
Galera Therapeutics all-time high quarterly cash and cash equivalents is $38.47 M
What is Galera Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, GRTX quarterly cash and cash equivalents has changed by -$9.80 M (-53.69%)